Downregulation of ABCB1 gene in patients with total hip or knee arthroplasty influences pharmacokinetics of rivaroxaban: a population pharmacokinetic-pharmacodynamic study-Reference-Cited by-同舟云学术

Downregulation of ABCB1 gene in patients with total hip or knee arthroplasty influences pharmacokinetics of rivaroxaban: a population pharmacokinetic-pharmacodynamic study

Published:2019-02-06 Issue:6 Volume:75 Page:817-824
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Zdovc Jurij,Petre Maja,Pišlar Mitja,Repnik Katja,Mrhar Aleš,Vogrin Matjaž,Potočnik Uroš,Grabnar Iztok^ORCID

Funder

Javna Agencija za Raziskovalno Dejavnost RS

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-019-02639-8/fulltext.html

Reference41 articles.

1. Agnelli G (2004) Prevention of venous thromboembolism in surgical patients. Circulation 110:4–13. https://doi.org/10.1161/01.CIR.0000150639.98514.6c

2. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:381S–453S. https://doi.org/10.1378/chest.08-0656

3. Gillespie W, Murray D, Gregg PJ, Warwick D (2000) Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery. J Bone Joint Surg Br 82:475–479. https://doi.org/10.1302/0301-620X.82B4.10452

4. Mueck W, Eriksson BI, Bauer KA, Borris L, Dahl OE, Fisher WD, Gent M, Haas S, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AGG (2008) Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet 47:203–216. https://doi.org/10.2165/00003088-200847030-00006

5. Duggan ST (2012) Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery. Am J Cardiovasc Drugs 12:57–72. https://doi.org/10.2165/11208470-000000000-00000

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of Rivaroxaban Hard Capsules vs. Film-Coated Tablets in Healthy White Volunteers;Acta Poloniae Pharmaceutica - Drug Research;2024-04-09

2. The Pharmacogenetic Variability Associated with the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory Study;Clinical Therapeutics;2024-04

3. Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions;Clinical Pharmacology in Drug Development;2023-11-23

4. Population pharmacokinetics of rivaroxaban in Chinese deep vein thrombosis patients and the exposure simulation for dosing recommendation;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-11

5. The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation;Human Genomics;2023-07-07